Wall Street Zen upgraded shares of Materialise (NASDAQ:MTLS – Free Report) from a buy rating to a strong-buy rating in a research note published on Saturday.
Materialise Price Performance
MTLS opened at $6.61 on Friday. The company has a debt-to-equity ratio of 0.18, a quick ratio of 2.24 and a current ratio of 2.42. The stock has a market capitalization of $390.45 million, a P/E ratio of 33.05 and a beta of 1.34. The company’s 50-day simple moving average is $6.74 and its two-hundred day simple moving average is $5.94. Materialise has a 52-week low of $4.78 and a 52-week high of $7.50.
Institutional Investors Weigh In On Materialise
Several institutional investors and hedge funds have recently added to or reduced their stakes in MTLS. Nano Cap New Millennium Growth Fund L P bought a new stake in Materialise in the 4th quarter worth approximately $555,000. Walleye Capital LLC bought a new position in shares of Materialise during the 2nd quarter valued at $150,000. Banque Transatlantique SA bought a new position in shares of Materialise during the 3rd quarter valued at $86,000. Millennium Management LLC bought a new position in shares of Materialise during the 4th quarter valued at $75,000. Finally, NewEdge Advisors LLC boosted its stake in shares of Materialise by 19,063.2% in the 2nd quarter. NewEdge Advisors LLC now owns 13,031 shares of the software maker’s stock worth $74,000 after buying an additional 12,963 shares during the last quarter. Hedge funds and other institutional investors own 19.30% of the company’s stock.
About Materialise
Materialise NV is a Belgium-based company specializing in 3D printing software and additive manufacturing services. Through its dual focus on software and printing, the company addresses a wide range of industries, including automotive, aerospace, consumer goods, and healthcare. Materialise’s offerings span from design and simulation tools to end-to-end production, delivering both standardized and highly customized parts across polymer and metal platforms.
On the software side, Materialise develops a suite of proprietary applications—such as Magics for data preparation, Mimics for medical image processing and patient-specific modeling, and Streamics for production workflow management.
Featured Stories
- Five stocks we like better than Materialise
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Receive News & Ratings for Materialise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Materialise and related companies with MarketBeat.com's FREE daily email newsletter.
